
About TINAVI Medical
TINAVI Medical is a publicly listed company based in Beijing (China) founded in 2005. Minimally invasive robot-assisted systems for spinal surgeries are developed. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. Its focus areas include Life Sciences, Surgical Instruments, Robotic Surgery and High Tech.
Company details
TINAVI Medical is developing minimally invasive robot-assisted surgical systems and complementary products. The company is developing Phecda, a robot-assisted surgical system designed to be used in both open and minimally-invasive spinal surgeries. It reduces the amount of intraoperative X-rays by up to 90 with a margin of error of less than 0.8 mm. The device takes intraoperative 3D or 2D images which help surgeons create a surgical plan including screw selection and drill trajectory simulation. The company has not received FDA or CE Mark approval as of July 2017. The company has received a registration license from CFDA.
- Headquarters Beijing, China
- Stage Public
- SectorsHealthcareIndustrial Goods & Manufacturing
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website tinavi.com
- Social LinkedIn
- Legal Name Tinavi Medical Technologies Co., Ltd. Class A
- Annual Revenue$39.83 M (USD)55.88as on Dec 31, 2025
- Net Profit-$26.1 M (USD)-50.87as on Dec 31, 2025
- EBITDA-$18.68 M (USD)-13.71as on Dec 31, 2025
IPO & Listings of TINAVI Medical
TINAVI Medical is a publicly listed company on the SSE with ticker symbol 688277 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Jul 2020
- Listed onSSE: 688277
- Listed entityTinavi Medical Technologies Co., Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE100004256
- Share price14.07 CNY (-3.03% on the day) · 2026-10-14
- Market capitalisation6,768,114,949.00 CNY
- EPS (diluted, trailing year)-0.43 CNY
- Volume (last session)3,714,685
Financials of TINAVI Medical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 278.8M CNY | -182.8M CNY | -130.8M CNY |
| 2024 | 178.9M CNY | -121.1M CNY | -115.0M CNY |
| 2023 | 209.2M CNY | -156.4M CNY | -167.1M CNY |
| 2022 | 155.8M CNY | -110.6M CNY | -124.7M CNY |
| 2021 | 154.8M CNY | -79.9M CNY | -99.2M CNY |
Detailed financial statements for TINAVI Medical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tinavi Medical
Complete news archive for TINAVI Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TINAVI Medical
TINAVI Medical was founded in 2005.
TINAVI Medical is headquartered in Beijing, China.
Annual revenue of TINAVI Medical is $39.83M as on Dec 31, 2025.
TINAVI Medical is developing minimally invasive robot-assisted surgical systems and complementary products. The company is developing Phecda, a robot-assisted surgical system designed to be used in both open and minimally-invasive spinal surgeries. It reduces the amount of intraoperative X-rays by up to 90 with a margin of error of less than 0.8 mm. The device takes intraoperative 3D or 2D images which help surgeons create a surgical plan including screw selection and drill trajectory simulation. The company has not received FDA or CE Mark approval as of July 2017. The company has received a registration license from CFDA.
Yes, TINAVI Medical is publicly traded on SSE under the ticker symbol 688277.
